Vaccination against multiple HPV types
- PMID: 16095627
- DOI: 10.1016/j.mbs.2005.05.004
Vaccination against multiple HPV types
Abstract
Vaccines against the most common human papillomavirus (HPV) types are currently under development. Epidemiologic data suggest that the transmission dynamics of different HPV types are not independent. Some studies indicate that interactions among HPV types are synergistic, where infection with one type facilitates concurrent or subsequent infection with another HPV type. Other studies point to antagonistic interference among HPV types. Here we develop a mathematical model to explore how these interactions may either enhance or diminish the effectiveness of vaccination programs designed to reduce the prevalence of the HPV types associated with cervical cancer. We analyze the local stability of the infection-free and boundary equilibria and characterize the conditions leading to a coexistence equilibrium. We also illustrate the results with numerical simulations using realistic model parameters. We show that if interactions among HPV types are synergistic, mass vaccination may reduce the prevalence of types that are not even included in the vaccine.
Similar articles
-
Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control.Vaccine. 2005 Mar 18;23(17-18):2388-94. doi: 10.1016/j.vaccine.2005.01.016. Vaccine. 2005. PMID: 15755633 Review.
-
[Vaccination against human papillomavirus for the prevention of cervical cancer].Ned Tijdschr Geneeskd. 2006 Jun 24;150(25):1380-4. Ned Tijdschr Geneeskd. 2006. PMID: 16841585 Review. Dutch.
-
Strategies for the prevention of cervical cancer by human papillomavirus vaccination.Best Pract Res Clin Obstet Gynaecol. 2005 Aug;19(4):531-44. doi: 10.1016/j.bpobgyn.2005.02.006. Epub 2005 Apr 12. Best Pract Res Clin Obstet Gynaecol. 2005. PMID: 16150392 Review.
-
Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines.J Infect Dis. 2005 Oct 1;192(7):1158-65. doi: 10.1086/444391. Epub 2005 Aug 29. J Infect Dis. 2005. PMID: 16136457
-
Human papillomavirus infection: an old disease, a new vaccine.Aust N Z J Obstet Gynaecol. 2006 Jun;46(3):180-5. doi: 10.1111/j.1479-828X.2006.00580.x. Aust N Z J Obstet Gynaecol. 2006. PMID: 16704468 Review.
Cited by
-
Assessing the best time interval between doses in a two-dose vaccination regimen to reduce the number of deaths in an ongoing epidemic of SARS-CoV-2.PLoS Comput Biol. 2022 Mar 25;18(3):e1009978. doi: 10.1371/journal.pcbi.1009978. eCollection 2022 Mar. PLoS Comput Biol. 2022. PMID: 35333872 Free PMC article.
-
Bias Due to Correlation Between Times-at-Risk for Infection in Epidemiologic Studies Measuring Biological Interactions Between Sexually Transmitted Infections: A Case Study Using Human Papillomavirus Type Interactions.Am J Epidemiol. 2016 Dec 15;184(12):873-883. doi: 10.1093/aje/kww152. Epub 2016 Dec 7. Am J Epidemiol. 2016. PMID: 27927619 Free PMC article.
-
The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting.Br J Cancer. 2007 Nov 5;97(9):1322-8. doi: 10.1038/sj.bjc.6604023. Epub 2007 Oct 9. Br J Cancer. 2007. PMID: 17923869 Free PMC article.
-
Model for assessing human papillomavirus vaccination strategies.Emerg Infect Dis. 2007 Jan;13(1):28-41. doi: 10.3201/eid1301.060438. Emerg Infect Dis. 2007. PMID: 17370513 Free PMC article.
-
Analysis of vaccination strategies in a heterosexual HPV transmission model with a case study in Xinjiang of China.Infect Dis Model. 2025 Jun 23;10(4):1153-1178. doi: 10.1016/j.idm.2025.06.004. eCollection 2025 Dec. Infect Dis Model. 2025. PMID: 40678791 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources